These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7337199)

  • 21. Theophylline levels and clinical response in asthmatic adults receiving long-term Uniphyl.
    Petty TL; Rollins DL
    Am J Med; 1985 Dec; 79(6A):73-6. PubMed ID: 2867679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum theophylline levels in asthmatic children after oral administration of two slow-release theophylline preparations.
    McKenzie S; Baillie E
    Arch Dis Child; 1978 Dec; 53(12):943-6. PubMed ID: 747398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative steady-state bioavailability of sustained-release theophylline preparations: Theo-Dur, Uni-Dur and Xanthium.
    Rojanasthien N; Kovjiriyapan K; Manorot M; Pothirat C
    Asian Pac J Allergy Immunol; 2001 Jun; 19(2):69-78. PubMed ID: 11699723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained-release theophylline preparations in asthmatic children. A short-term comparison of two products and the relationship of serum theophylline levels and pulmonary function changes.
    Rachelefsky G; Rohr A; Katz R; Wo J; Gracey V; Spector S; Siegel S; Mickey MR
    Am J Dis Child; 1986 Apr; 140(4):336-40. PubMed ID: 3513540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained-release theophylline for treatment of asthma in preschool children.
    Simons FE; Luciuk GH; Simons KJ
    Am J Dis Child; 1982 Sep; 136(9):790-3. PubMed ID: 7114002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of the theophylline pharmacokinetics of sustained-release theophylline (Theodur) dry syrup in children].
    Okuma M; Iikura Y
    Arerugi; 1999 Jun; 48(6):589-96. PubMed ID: 10423899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Slow-release theophylline for the treatment of asthmatic children].
    Iwasaki E; Baba M
    Nihon Rinsho; 1996 Nov; 54(11):3102-7. PubMed ID: 8950962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained release theophylline for the forgetful asthmatic.
    Weinstein AG
    Ann Allergy; 1985 Oct; 55(4):563-7. PubMed ID: 4051262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained release theophylline in nocturnal asthma.
    Elias-Jones AC; Higenbottam TW; Barnes ND; Godden DJ
    Arch Dis Child; 1984 Dec; 59(12):1159-61. PubMed ID: 6395810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained-release theophylline therapy for chronic childhood asthma.
    Bell T; Bigley J
    Pediatrics; 1978 Sep; 62(3):352-8. PubMed ID: 704210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability and diurnal variation in absorption of sustained release theophylline in asthmatic children.
    Coulthard KP; Birkett DJ; Lines DR; Grgurinovich N; Grygiel JJ
    Eur J Clin Pharmacol; 1983; 25(5):667-72. PubMed ID: 6686557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
    van der Vet AP; Drost RH; Kreukniet J; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [24-hour lung function in asthmatic patients: chrono-optimal theophylline therapy as once-daily Euphylong administration vs conventional twice-daily administration].
    D'Alonzo GE; Smolensky MH; Feldman S; Gianotti LA; Emerson MB; Staudinger HW; Sauter R; Steinijans VW
    Pneumologie; 1991 Nov; 45 Suppl 4():834-41. PubMed ID: 1812476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience with theophylline for the management of chronic asthma.
    Weinberger M; Hendeles L
    Eur J Respir Dis Suppl; 1980; 109():120-33. PubMed ID: 6777183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA; Straughan AB
    Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Slow-release theophyllines: serum and saliva levels in asthmatic children].
    Souto Martínez I; Duque Hernández J; Galván Tudela L; Alvarez Sanz E; Díaz Gómez MI
    An Esp Pediatr; 1988 Jun; 28(6):513-6. PubMed ID: 3195854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rise and fall of serum theophylline concentration: a comparison of sustained-release formulations in volunteers with rapid theophylline clearance.
    Mucklow JC; Kuhn S
    Br J Clin Pharmacol; 1985 Dec; 20(6):589-96. PubMed ID: 4091990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absorption characteristics of once-a-day slow-release theophylline preparation in children with asthma.
    Pedersen S; Steffensen G
    J Pediatr; 1987 Jun; 110(6):953-9. PubMed ID: 3585612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of children with a single dose a day of sustained release theophylline.
    Pedersen S
    Br J Clin Pharmacol; 1982 Aug; 14(2):290-1. PubMed ID: 7104183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.